Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests a builder of well being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R amp D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. Orion s net sales in amounted to EUR million and the company had about , employees. Orion s A and B shares are listed on NASDAQ OMX Helsinki.
Quote | Orion Corp New B Shs (OTCMKTS:ORINF)
Last: | $47.16 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $47.16 |
High: | $0 |
Low: | $0 |
Volume: | 4 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Orion Corp New B Shs (OTCMKTS:ORINF)
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 1 JULY 2024 at 15:15 EEST Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metas...
ORION CORPORATION PRESS RELEASE 03 June 2024 at 09.30 EEST Orion is developing the Finnish life science industry in a unique collaboration project Orion is participating in a project led by the University of Turku for which Business Finland recently granted 11.7M€ funding. Th...
Message Board Posts | Orion Corp New B Shs (OTCMKTS:ORINF)
Subject | By | Source | When |
---|---|---|---|
Emylers: ORINF Financials Monday, July 14, 2014 10:32:01 PM Orion Corporation OY Data is unavailable | Emylers | investorshangout | 07/15/2014 2:32:03 AM |
chartguy89: ORINF 25.00 Stock Charts $ORINF 1 Month Chart | chartguy89 | investorshangout | 03/09/2014 6:43:05 AM |
chartguy89: ORINF Stock Charts Last: -2.00 Friday, February 28, 2014 at 1:29:06 PM $ORINF 1 | chartguy89 | investorshangout | 02/28/2014 6:29:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Orion Corp New B Shs Company Name:
ORINF Stock Symbol:
OTCMKTS Market:
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 1 JULY 2024 at 15:15 EEST Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metas...
ORION CORPORATION PRESS RELEASE 03 June 2024 at 09.30 EEST Orion is developing the Finnish life science industry in a unique collaboration project Orion is participating in a project led by the University of Turku for which Business Finland recently granted 11.7M€ funding. Th...
ORION CORPORATION PRESS RELEASE 26 JANUARY 2024 at 09.00 EET Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024 Orion presented yesterday at the 2024 ASCO GU Cancers Symposium a poster with additional data from the ongoing Phase II CYPIDES trial evaluating the safety...